Shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Free Report) traded up 0.7% during mid-day trading on Wednesday . The company traded as high as $1.40 and last traded at $1.37. 45,888 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 5,230,312 shares. The stock had previously closed at $1.36.
Bluejay Diagnostics Trading Up 0.7%
The company has a market cap of $2.04 million, a PE ratio of -0.01 and a beta of 0.48. The business’s 50-day simple moving average is $1.54 and its 200-day simple moving average is $2.35.
Bluejay Diagnostics (NASDAQ:BJDX – Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($1.41) earnings per share for the quarter.
About Bluejay Diagnostics
Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.
Further Reading
- Five stocks we like better than Bluejay Diagnostics
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Amazon’s Chart Just Flashed a Pennant Pattern—Here’s What to Do
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Undervalued Stocks Analysts Are Loving Right Now—Should You?
- Stock Splits, Do They Really Impact Investors?
- Williams-Sonoma Q2 Results Prove Its Buy-and-Hold Quality
Receive News & Ratings for Bluejay Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bluejay Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
